Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA AR-42 GDSC1000 pan-cancer AAC -0.034 0.3
mRNA PI-103 GDSC1000 pan-cancer AAC -0.034 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.06 0.3
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.057 0.3
mRNA tosedostat CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
Download CSV